Skip to content
Screener

Innoviva, Inc. INVA Q2 2025 earnings

Reported August 6, 2025 · Before market open

Revenue$100.3MBeat by $9.4M
EPS$0.77Beat by $0.20
Revenue estimate$90.9M
EPS estimate$0.57

Next report

Nov 4, 2026 (in a month)
Revenue estimate$115.3M
EPS estimate$0.49

Financials

Q2 2025

Income statement

See full
Revenue$100.3M+0.4%
Gross profit$83.1M-2.2%
Operating income$48.8M-10.9%
Net income$63.7M+284%
EPS (diluted)$0.77+240%

Balance sheet

See full
Cash & equivalents$397.5M+83.2%
Total debt$450.9M0.0%
Total assets$1.3B+8.9%

Cash flow

See full
Operating cash flow$44.1M+0.8%
CapEx-—
Free cash flow$44.1M+0.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.3B+26.8%
Enterprise value$1.35B+7.5%
P/E33.6×+26.5×
P/S3.5×+0.4×

Profitability

See full
Gross margin83.1%+2.0pp
Operating margin47.7%+6.1pp
Net margin10.4%-33.6pp
FCF margin54.1%+6.4pp

Returns & leverage

See full
Current ratio2.6×-10.1×

Segments

By product

See full
Giapreza$17.3M+32.2%
Cost Reimbursement$800.0K—

FAQ

When did Innoviva, Inc. report Q2 2025 earnings?
Innoviva, Inc. (INVA) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Innoviva, Inc.'s Q2 2025 revenue and EPS?
Innoviva, Inc. reported revenue of $100.3M and eps of $0.77 for Q2 2025.
Did Innoviva, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $90.9M by $9.4M. EPS beat the consensus estimate of $0.57 by $0.20.
How did Innoviva, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.0% from $103.4M a year earlier and eps grew 13.2% from $0.68.
Where can I find Innoviva, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-074730) and the 10-Q periodic report (0000950170-25-104126) directly on SEC EDGAR. The filing index links above go to sec.gov.